Prescription monitoring

Formularies and treatment protocols, without economic sanctions or incentives Prescription monitoring (with/without feedback)... 

All the countries studied carry out prescription monitoring processes of one sort or another, following the lead of the UK, although not always systematically. Moreover, most countries do not reach the extreme of penalizing malpractice. In Spain, personalized information is gathered, more with the aim... 

Noncompliance can be measured by patient reporting, prescription monitoring, and electronic inhalers. Each method has advantages and disadvantages. 

Application diagnostics, prescriptive, monitor/control, design/plan-ning, training... 

A good example of a prescriptive approach to quality assessment is the protocol outlined in Figure 15.2, published by the Environmental Protection Agency (EPA) for laboratories involved in monitoring studies of water and wastewater. Independent samples A and B are collected simultaneously at the sample site. Sample A is split into two equal-volume samples, and labeled Ai and A2. Sample B is also split into two equal-volume samples, one of which, Bsf, is spiked with a known amount of analyte. A field blank. Dp, also is spiked with the same amount of analyte. All five samples (Ai, A2, B, Bsf, and Dp) are preserved if necessary and transported to the laboratory for analysis. 

Example of a prescriptive approach to quality assurance. Adapted from Environmental Monitoring and Support Laboratory, U.S. Environmental Protection Agency, "Handbook for Analytical Quality Control in Water and Wastewater Laboratories," March 1979. 

They have indications exclusively appropriate to traditional herbal medicinal products which, by virtue of their composition and purpose, are intended and designed for use without the supervision of a medical practitioner for diagnostic purposes or for prescription or monitoring of treatment. 

Watchful waiting and safety-net antibiotic prescriptions are approaches being used more frequently to attenuate microbial resistance and avoid unnecessary adverse events and costs of antibiotics. Observation is practiced extensively in Europe and involves monitoring for 48 to 72 hours after diagnosing AOM to see if spontaneous resolution will occur. Observation or delayed antibiotic therapy should be considered only in otherwise healthy children without recurrent disease (Fig. 69-1) and only if proper follow-up and good communication exist between clinicians and the parent/caregiver.4,5,16... 

In Chapter 9, lecturers V. Ortun Rubio of Pompeu Fabra University and L. Cabiedes Miragaya of the University of Oviedo address the subject of measures intended as a way of influencing prescriber decisions. The authors place special emphasis on analysing prescriber incentive policies, distinguishing between incentives of a financial nature (both coercive and non-coercive) and non-financial incentives (information, training, treatment protocols, monitoring of prescription practices, cost-effectiveness guidelines, interaction with other professionals, pressure from patients and so on). The authors advocate incentive policies based on a combination of financial and non-financial incentives. 

Non-coercive Monitoring of prescribing patterns Measures encouraging rationalization of prescription Pharmaceutical care Remuneration system for pharmacies... 

Certainly Richard raises valid points, and you can hardly fault his prescription for monitoring and improving the results. However, is that considered, or should that be considered a requirement for validation, or even a necessary part of the validation process The response comment to Richard at the time was as follows ... 

Patients taking abortive therapy should be monitored for frequency of use of prescription and nonprescription medications and for side effects of medications. 

Heeley, E., et al., "Prescription-Event Monitoring and Reporting of Adverse Drug Reactions," Lancet, 358, 1872-1873 (2001). 

Rawson NSB, Pearce GL, Inman WHW. Prescription event monitoring methodology and recent progress. / Clin Epidemiol 1990 43 509-22. 

---